Percutaneous Tibial Nerve Stimulation (PTNS) Articles

BERKELEY, CA (UroToday.com) - There is much information available to the public for patients and prescribers about the different treatment options for overactive and neurogenic bladder.

BERKELEY, CA (UroToday.com) - Overactive bladder (OAB) is a chronic condition significantly affecting the lives of 34 million U.S. adults.^[1]

WILLIAMSBURG, VA USA (UroToday.com) - Dr. Eric Rovner opened his presentation by asking, "what is refractory OAB?” and he went on to state that doing a search on Medline does not give much in the way of results as far as the term “refractory” is concerned.

LAS VEGAS, NV USA (UroToday.com) - The Study of Urgent® PC versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms (SUmiT) was a double-blind, randomized, sham-controlled trial demonstrating the efficacy of PTNS in treating OAB. The purpose of this secondary analysis was to evaluate the potential differences in treatment efficacy based on demographic and baseline health factors, and to analyze the treatment effect after 6 and 12 interventions.

LAS VEGAS, NV USA (UroToday.com) - Dr. Scott MacDiarmid started by mentioning the new guidelines for diagnosis and treatment of OAB (non-neurogenic) in adults.  He quickly went over first-line treatment which includes behavioral therapies for all patients, and this may be combined with antimuscarinics that are listed under second-line treatment.

LAS VEGAS, NV USA (UroToday.com) - Purpose: To report on the 36-month final results of the Sustained Therapeutic Effects of Percutaneous Tibial Nerve Stimulation (STEP) Study, which examined the safety and effectiveness of percutaneous tibial nerve stimulation (PTNS) with the Urgent® PC Neuromodulation System for overactive bladder syndrome (OAB).